ST. PAUL, Minn. –
3M today is announcing the availability of PREVENA RESTOR AXIO•FORM™ Incision Management System, designed to manage post-operative incisions, as well as the surrounding soft tissue envelope, following the orthopedic surgical repair of lower extremity fractures. PREVENA RESTOR AXIO•FORM™ helps stabilize the incision & surrounding soft tissue, reduce edema, and help enhance post-operative recovery. This is the third offering in the PREVENA RESTOR™ Therapy portfolio, launched in 2019, to optimize post-surgical care and expand the company’s specialty surgical offerings.
“Patients recovering from lower extremity fractures often experience complications which can potentially compromise the healing process, leading to delayed rehabilitation and poor functional outcomes,” said Dr. Brett D. Crist, MD, FAAOS, FACS, FAOA, Director of Orthopaedic Surgery, University of Missouri School of Medicine, who participated in the pre-market pilot. “The PREVENA RESTOR AXIO•FORM™ System provides a unique solution for post-surgical incision and soft tissue envelope management for the lower extremity – which can be one of the most complex and challenging anatomical areas. The expanded coverage and precision design lend themselves to better conformity on the surgical site, providing us confidence for our patients’ recovery.”
The PREVENA RESTOR AXIO•FORM™ System encompasses the same proven technology as the PREVENA™ Incision Management System, with added benefits including:
“Not all surgical incisions are the same size, and orthopedic fracture repairs can be complex, which is why we offer clinicians a variety of products to accommodate their individual patient’s needs,” said Ronald Silverman, MD, FACS, Chief Medical Officer, 3M. “Given the current pandemic, it is even more critical to minimize the length of hospital stays for patients and, once they return home, lessen the number of in-person visits during recovery. PREVENA RESTOR AXIO•FORM™ System aims to get patients home quickly and safely post-surgery, which is a priority now more than ever.”
The PREVENA RESTOR AXIO•FORM™ System was made commercially available in August 2020. Information on the PREVENA RESTOR AXIO•FORM™ System is available on the American Orthopedic Foot & Ankle Society (AOFAS) and Orthopedic Trauma Association (OTA) annual conference websites.
“Our team at 3M is pleased that, with the introduction of the PREVENA RESTOR AXIO•FORM™ System, we are further advancing how orthopedic surgeons care for patients recovering from lower extremity fractures by rethinking recovery and reimagining the traditional applications of negative pressure—all backed by the undisputed outcomes of PREVENA™ Therapy,” said Mark Colin, Vice-President, 3M Medical Solutions Division.
About PREVENA™ Therapy & PREVENA RESTOR AXIO•FORM™ Incision Management System
The PREVENA™ Therapy System, launched in 2010, is the first disposable negative pressure system designed specifically for the management of closed surgical incisions. PREVENA™ Therapy Systems removes fluid away from the surgical incision via the application of -125mmHg continuous negative pressure.
The PREVENA RESTOR™ Incision Management System is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudates via the application of negative pressure wound therapy.
Please refer to the PREVENA RESTOR AXIO•FORM™ System Instructions For Use for important safety information.
At 3M, we apply science in collaborative ways to improve lives daily. With $33 billion in sales, our 93,000 employees connect with customers all around the world. Learn more about 3M’s creative solutions to the world’s problems at www.3M.com or on Twitter @3M or @3MNews.